BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Tazeen Ahmad does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 PRTAProthena Corporation plc | Sell | $4.00 | May 2025 | −96.3% | Miss |
 DNLIDenali Therapeutics Inc | Buy | $27.00 | May 2025 | +15.4% | Miss |
 STROSutro Biopharma | Sell | $0.80 | May 2025 | −240.7% | Hit |
| STROSutro Biopharma | Sell | $1.00 | Mar 2025 | −147.2% | Hit |
| DNLIDenali Therapeutics Inc | Buy | $28.00 | Mar 2025 | +35.8% | Miss |
 FDMT4D Molecular Therapeutics Inc | Buy | $40.00 | Mar 2025 | +109.1% | Miss |
 KALVKalvista Pharmaceuticals Inc | Buy | $22.00 | Dec 2024 | +70.5% | Miss |
 APLSApellis Pharmaceuticals Inc | Buy | $47.00 | Nov 2024 | −31.0% | Miss |
 FULCFulcrum Therapeutics Inc | Sell | $2.00 | Sep 2024 | −130.2% | Miss |
| STROSutro Biopharma | Buy | $12.00 | May 2024 | −73.1% | Miss |
 FATEFate Therapeutics Inc | Sell | $6.00 | Mar 2024 | +88.3% | Hit |
 ANNXAnnexon Inc | Buy | $10.00 | Mar 2024 | −66.3% | Miss |
 PHVSPharvaris BV | Sell | $11.00 | Dec 2023 | +36.0% | Miss |
 GRTXGalera Therapeutics Inc | Buy | $7.00 | Feb 2023 | −113.7% | Miss |
 PRLDPrelude Therapeutics Inc | Sell | $6.00 | Nov 2022 | +47.4% | Hit |
 SRZNSurrozen Inc | Sell | $1.00 | Nov 2022 | +45.2% | Hit |
| PHVSPharvaris BV | Sell | $13.00 | Aug 2022 | −77.3% | Hit |
| GRTXGalera Therapeutics Inc | Sell | $2.00 | May 2022 | −85.3% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.